Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma

Fig. 2

Low BCAM expression was associated with several clinicopathological characteristics and poor prognosis in ccRCC. A BCAM mRNA expression was associated with pT stage in ccRCC. B BCAM mRNA expression was not associated with pN stage in ccRCC. C BCAM mRNA expression was associated with metastatic status in ccRCC. D BCAM mRNA expression was associated with tumor grading in ccRCC. E BCAM protein expression was associated with tumor grading in ccRCC. F BCAM protein expression was associated with pan-cancer subtype in ccRCC. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. G Kaplan–Meier analysis of the association between BCAM expression and OS in ccRCC, pRCC, chRCC

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us